Skip to content
Menu

Evidence review

Hallandale Pharmacy: What It Is and Who Uses It

Hallandale is a 503A compounding pharmacy in Fort Lauderdale that fills for prescribers, not the public. What that means, and the six companies naming it.

By The Desk, Provider Intelligence Desk
On this page

The Desk's #1 pick

CoreAge Rx

A

The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

Check availability
Semaglutide
$99/mo only as a 12-month plan paid in full ($1,188 in one charge); the lander says "starting at, based on a 12-month plan paid in full"; no month-to-month price is published; same price at every dose; compounded injectable
Tirzepatide
$149/mo only as a 12-month plan paid in full ($1,788 in one charge); no month-to-month price is published; same price at every dose; compounded injectable
Coverage
All 50 states
Access
Compounded

Advertising disclosure · we may earn a commission at no extra cost to you. It never changes what we write about a product — an unflattering finding on a paying provider stays in.

Also here

yourEra

B

A compounded desk that advertises low floors — semaglutide from $79/mo, tirzepatide from $159/mo — with the plan price behind its intake, plus a NAD+ and microdosing menu, across all 50 states.

Check yourEra availability

Hallandale is the pharmacy name that turns up most often when a GLP-1 telehealth company is willing to say who fills its prescriptions. Six companies tracked on this site name it. It is worth knowing what kind of pharmacy it is, because the category it belongs to decides which rules its vials were made under and who inspects the building. Checked August 29, 2026.

A 503A pharmacy, in its own words

Hallandale states its category itself, twice, on two different pages. Its about page says: "As a 503A designated pharmacy, we are held to the standards of USP"2. Its quality page repeats it: "As a 503A designated pharmacy, adhering to USP 797 standards is fundamental to our operations"3.

That single sentence settles a lot. A 503A pharmacy compounds against a prescription written for a named patient. It is licensed and supervised by state boards of pharmacy rather than inspected by the FDA on a manufacturing schedule, and the drugs it makes sit outside the federal current-good-manufacturing-practice regime. The FDA draws the line this way: "Drugs compounded in outsourcing facilities are subject to current good manufacturing practice (CGMP) requirements. By contrast, drugs compounded by a licensed pharmacist in a state-licensed pharmacy or federal facility, or by a physician, in accordance with the conditions of section 503A of the FD&C Act, are not"5.

The claim checks out against the federal register of the other category. FDA publishes a weekly table of every facility registered as an outsourcing facility under section 503B. On the version read August 29, 2026, that table carried 98 facilities, and Hallandale was not among them by name or by a South Florida address4. That is not a mark against the pharmacy; it is confirmation that it is what it says it is.

What it makes and who it makes it for

The company gives its own founding date twice and does not agree with itself: its about page says "Since our establishment in 2004," while the site footer and homepage carry "Since 2003"21. Both dates are on the company's own pages as of the check date, and we are not going to pick one for them.

The address is consistent: "2666 SW 36th St / Fort Lauderdale, FL 33312"2. On accreditation the pharmacy is specific: "At Hallandale Pharmacy, we hold accreditation from PCAB (Pharmacy Compounding Accreditation Board)"3. PCAB accreditation is voluntary and is granted by an accrediting body, not by the FDA — it is a real signal about process discipline, and it is not a federal approval of any drug. The pharmacy also states that "Each sterile batch of our products undergoes rigorous analytic testing to ensure its quality and safety"3 and that it is "LegitScript Certified"1.

The catalog is broad — the homepage lists categories from hormone replacement and dermatology to fertility, ophthalmology and peptide therapy — and it includes GLP-1 preparations sold as multi-dose vials at several fill volumes, with product pages for semaglutide and tirzepatide flex-dose injectables1.

The business model is the part patients most often miss: Hallandale sells to prescribers, not to the public. Its own pages describe a network of practitioner collaborations and put the count at more than 15,000 prescribing practitioners2, and the site's main calls to action are provider registration and provider login rather than a consumer checkout1. You do not buy from Hallandale. A clinician you found somewhere else sends a prescription there, and the vial arrives at your door with a telehealth company's name on the invoice.

FDA's record, read rather than assumed

We read FDA's warning-letter index in full on August 29, 2026: 3,664 letters, of which 59 carry a compounding subject. Every one of those 59 letter bodies was fetched and searched for Hallandale by name and by its Fort Lauderdale address. There were no matches. The same pass returns three letters addressed to Empower, so the search was working when it found nothing here.

One caution on how much weight that carries. FDA addresses letters to legal entities at street addresses, and a trading name is not always the entity name — which is exactly why the search covered the address as well as the name. It is a dated, bounded absence, not a clean bill of health, and it says nothing about state board of pharmacy actions. FDA's own outsourcing-facility page makes that limit explicit: its table "does not include State Board of Pharmacy actions, if any," and directs readers to check with the state board where the facility is located4.

Who dispenses through Hallandale

Six of the 507 companies tracked here name Hallandale in their own public disclosures, computed from our record on August 29, 2026: Ondra Health, which names every dispensing pharmacy it uses; Vytora Health, which publishes pharmacy addresses alongside the names; Cora Health, which names Hallandale and a second 503A partner on its own pages; NuuVim; Premium Health, which names three pharmacy partners; and Pomegranate Health, whose pricing page names six. Companies that publish no pharmacy name at all cannot appear in a count like this, so six is the number that discloses, not the number that uses.

What a named pharmacy is worth to you

Naming the pharmacy is the single most useful thing a telehealth company can do for a patient's ability to check its work, and most of them do not do it. Once you have the name you can search your own state board of pharmacy for its nonresident pharmacy license, search FDA's outsourcing-facility table to see which regulatory category it is in, and search FDA's warning-letter database on the legal entity. None of that is available to someone whose invoice says only "your prescription has shipped."

What a name does not buy you is a federal quality guarantee. FDA's position on the whole category is one sentence: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed"5. That is true of Hallandale's vials and of every other compounded vial in this market.

The other pharmacies named most often here have their own pages: Empower, Red Rock and Olympia. For the rules behind the categories, read is compounded GLP-1 legit and safe; for the checks that separate a licensed operator from a storefront, how to tell if a GLP-1 provider is legit; for coverage, GLP-1 telehealth by state; and for what the compounded market actually charges, compounded semaglutide cost. The sources behind these pages are indexed in our research library.

Frequently asked questions

Is Hallandale Pharmacy a 503A or a 503B facility?

503A. The pharmacy says so on both its about page and its quality page, and FDA's registered outsourcing facilities table — 98 facilities on the version read August 29, 2026 — does not list it. A 503A pharmacy compounds against a prescription for a named patient and is supervised by state boards of pharmacy rather than inspected by FDA on a manufacturing schedule.

Can I buy compounded semaglutide directly from Hallandale?

No. Hallandale fills for prescribers. Its own pages describe a network of more than 15,000 prescribing practitioners and its calls to action are provider registration and provider login, not a consumer checkout. You reach it through a clinician or a telehealth company.

Is Hallandale accredited?

It states that it holds accreditation from PCAB, the Pharmacy Compounding Accreditation Board, and that it is LegitScript Certified. Both are voluntary third-party programs. Neither is an FDA approval of any drug it compounds.

Has Hallandale received an FDA warning letter?

None appears in FDA's warning-letter index as read in full on August 29, 2026 — 3,664 letters, of which the 59 with a compounding subject were fetched and searched by name and by the Fort Lauderdale address. That is a dated absence rather than a clearance, and FDA's table separately notes that it does not include state board of pharmacy actions.

Which GLP-1 companies use Hallandale?

Six of the 507 companies tracked here name it as of August 29, 2026: Ondra Health, Vytora Health, Cora Health, NuuVim, Premium Health and Pomegranate Health. Companies that publish no pharmacy name cannot be counted either way.

References

  1. Hallandale Pharmacy (2026). Home — Hallandale Pharmacy. HallandaleRx.com. https://hallandalerx.com/
  2. Hallandale Pharmacy (2026). About Hallandale Pharmacy. HallandaleRx.com. https://hallandalerx.com/about/
  3. Hallandale Pharmacy (2026). Quality — Hallandale Pharmacy. HallandaleRx.com. https://hallandalerx.com/quality/
  4. U.S. Food and Drug Administration (2026). Registered Outsourcing Facilities. FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
  5. U.S. Food and Drug Administration (2025). Compounding and the FDA: Questions and Answers. FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.